During the past decade, DHR Health Institute for Research and Development conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 1 clinical trials were completed, i.e. on average, 6.7% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 1 clinical trials were completed. i.e. 7.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "DHR Health Institute for Research and Development" #1 sponsor was "National Cancer Institute (NCI)" with 5 trials, followed by "Sohail Rao" with 2 trials sponsored, "Adaptive Phage Therapeutics, Inc." with 1 trials sponsored, "BioNTech SE" with 1 trials sponsored and "DHR Health Institute for Research and Development" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "DHR Health Institute for Research and Development" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "George Clinical Pty Ltd" with 1 trials as a collaborator, "Jaeb Center for Health Research" with 1 trials as a collaborator and "NRG Oncology" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "DHR Health Institute for Research and Development" are "COVID-19" (3 trials), "Chronic Lymphocytic Leukemia" (2 trials), "Colon Adenocarcinoma" (2 trials), "Small Lymphocytic Lymphoma" (2 trials) and "Ann Arbor Stage III Hodgkin Lymphoma" (1 trials). Many other conditions were trialed in "DHR Health Institute for Research and Development" in a lesser frequency.

Most popular intervention types in "DHR Health Institute for Research and Development" are "Biological" (9 trials), "Drug" (8 trials), "Other" (8 trials), "Procedure" (4 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Biospecimen Collection" (4 trials), "Computed Tomography" (4 trials), "Quality-of-Life Assessment" (4 trials), "Atezolizumab" (3 trials) and "Fluorouracil" (3 trials). Other intervention names were less common.

The vast majority of trials in "DHR Health Institute for Research and Development" are 15 trials for "All" genders.

Currently, there are NaN active trials in "DHR Health Institute for Research and Development". undefined are not yet recruiting, 9 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in DHR Health Institute for Research and Development, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in DHR Health Institute for Research and Development, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".